CAS 121808-62-6
:Pidotimod
- (4R)-3-[[(2S)-5-Oxo-2-pyrrolidinyl]carbonyl]-4-Thiazolidinecarboxylic acid
- 4-Thiazolidinecarboxylic acid, 3-[(5-oxo-2-pyrrolidinyl)carbonyl]-, [R-(R*,S*)]-
- 4-Thiazolidinecarboxylic acid, 3-[[(2S)-5-oxo-2-pyrrolidinyl]carbonyl]-, (4R)-
- Adimod
- Axil (pharmaceutical)
- Onaka
- Pidotimond
- Pigitil
- Polimod
- Pidotimod
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Pidotimod
CAS:Formula:C9H12N2O4SPurezza:>98.0%(HPLC)(T)Colore e forma:White to Almost white powder to crystalPeso molecolare:244.27Pidotimod
CAS:Pidotimod is a synthetic dipeptide with immunomodulatory properties.Formula:C9H12N2O4SPurezza:97.56% - 99.74%Colore e forma:Almost White To White Crystalline PowderPeso molecolare:244.268(R)-3-((S)-5-Oxopyrrolidine-2-Carbonyl)Thiazolidine-4-Carboxylic Acid
CAS:(R)-3-((S)-5-Oxopyrrolidine-2-Carbonyl)Thiazolidine-4-Carboxylic AcidFormula:C9H12N2O4SPurezza:98%Peso molecolare:244.27Pidotimod
CAS:Prodotto controllatoApplications Immunostimulant used in patients with cell-mediated immunodepression.
References Gu, C., et al.: Pharm. Res., 25, 979 (2008), Fliri, A., et al.: J. Med. Chem., 52, 8038 (2009), Giagulli, C., et al.: Int. Immunopharmacol., 9, 1366 (2009),Formula:C9H12N2O4SColore e forma:NeatPeso molecolare:244.27Pidotimod - Bio-X ™
CAS:Pidotimod is a small molecule (dipeptide) that acts as immunomodulator. It activates the immune system by binding to Toll-like receptor (TLR) 4 and TLR2 and it is involved in the regulation of TLRs signaling pathways. Pidotimod has chemokine activity on CXC chemokine receptor 3 (CXCR3) that triggers monocyte adhesion and migration by activation of tyrosine phosphorylation-based cell signaling. Recent studies showed that pidotimod can be used to treat acute respiratory tract infections (RTIs) and its pharmacokinetic studies has shown its ability to boost the immunoresponse and favouring the increase in the level of immunoglobulins (IgA, IgM, IgG) and T-lymphocytes (CD3+, CD4+). Pidotimod also exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory molecules such as IL-6 and TNF-α, which are linked to autoimmune diseases.
Formula:C9H12N2O4SColore e forma:PowderPeso molecolare:244.27 g/mol(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:Formula:C9H12N2O4SPurezza:98%Colore e forma:SolidPeso molecolare:244.27Pidotimod
CAS:(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acidFormula:C9H12N2O4SPurezza:98%Peso molecolare:244.27Ref: ST-EA-CP-P172000
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaPidotimod
CAS:Pidotimod is a small molecule (dipeptide) that acts as immunomodulator. It activates the immune system by binding to Toll-like receptor (TLR) 4 and TLR2 and it is involved in the regulation of TLRs signaling pathways. Pidotimod has chemokine activity on CXC chemokine receptor 3 (CXCR3) that triggers monocyte adhesion and migration by activation of tyrosine phosphorylation-based cell signaling. Recent studies showed that pidotimod can be used to treat acute respiratory tract infections (RTIs) and its pharmacokinetic studies has shown its ability to boost the immunoresponse and favouring the increase in the level of immunoglobulins (IgA, IgM, IgG) and T-lymphocytes (CD3+, CD4+). Pidotimod also exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory molecules such as IL-6 and TNF-α, which are linked to autoimmune diseases
Formula:C9H12N2O4SPurezza:Min 98%Colore e forma:White PowderPeso molecolare:244.27 g/mol











